These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4352972)

  • 1. Prophylaxis and immunization in mice by use of virus-free defective T particles to protect against intracerebral infection by vesicular stomatitis virus.
    Doyle M; Holland JJ
    Proc Natl Acad Sci U S A; 1973 Jul; 70(7):2105-8. PubMed ID: 4352972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution mapping reveals the mechanism and contribution of genome insertions and deletions to RNA virus evolution.
    Aguilar Rangel M; Dolan PT; Taguwa S; Xiao Y; Andino R; Frydman J
    Proc Natl Acad Sci U S A; 2023 Aug; 120(31):e2304667120. PubMed ID: 37487061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective Interfering Viral Particle Treatment Reduces Clinical Signs and Protects Hamsters from Lethal Nipah Virus Disease.
    Welch SR; Spengler JR; Harmon JR; Coleman-McCray JD; Scholte FEM; Genzer SC; Lo MK; Montgomery JM; Nichol ST; Spiropoulou CF
    mBio; 2022 Apr; 13(2):e0329421. PubMed ID: 35297677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue virus-free defective interfering particles have potent and broad anti-dengue virus activity.
    Li D; Lin MH; Rawle DJ; Jin H; Wu Z; Wang L; Lor M; Hussain M; Aaskov J; Harrich D
    Commun Biol; 2021 May; 4(1):557. PubMed ID: 33976375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmissible Viral Vaccines.
    Bull JJ; Smithson MW; Nuismer SL
    Trends Microbiol; 2018 Jan; 26(1):6-15. PubMed ID: 29033339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of infection spread by co-transmitted defective interfering particles.
    Baltes A; Akpinar F; Inankur B; Yin J
    PLoS One; 2017; 12(9):e0184029. PubMed ID: 28915264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The brain parenchyma has a type I interferon response that can limit virus spread.
    Drokhlyansky E; Göz Aytürk D; Soh TK; Chrenek R; O'Loughlin E; Madore C; Butovsky O; Cepko CL
    Proc Natl Acad Sci U S A; 2017 Jan; 114(1):E95-E104. PubMed ID: 27980033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting Genetic Interference for Antiviral Therapy.
    Tanner EJ; Kirkegaard KA; Weinberger LS
    PLoS Genet; 2016 May; 12(5):e1005986. PubMed ID: 27149616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Single-Cell Kinetics of Virus Infections in the Presence of Defective Interfering Particles.
    Akpinar F; Timm A; Yin J
    J Virol; 2016 Feb; 90(3):1599-612. PubMed ID: 26608322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In memoriam John J. Holland (1929-2013): a pioneer in molecular virology.
    Spindler KR; Semler BL
    J Virol; 2014 Jun; 88(11):5903-5. PubMed ID: 24623431
    [No Abstract]   [Full Text] [Related]  

  • 11. Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?
    Dimmock NJ; Easton AJ
    J Virol; 2014 May; 88(10):5217-27. PubMed ID: 24574404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress with hepatitis B virus-editorial review.
    Robinson WS
    West J Med; 1978 Feb; 128(2):153-7. PubMed ID: 18748146
    [No Abstract]   [Full Text] [Related]  

  • 13. Contingent neutrality in competing viral populations.
    Quer J; Hershey CL; Domingo E; Holland JJ; Novella IS
    J Virol; 2001 Aug; 75(16):7315-20. PubMed ID: 11462003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A defective interference-like phenomenon of human hepatitis B virus in chronic carriers.
    Yuan TT; Lin MH; Chen DS; Shih C
    J Virol; 1998 Jan; 72(1):578-84. PubMed ID: 9420261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous interference resulting from the presence of defective particles of human immunodeficiency virus type 1.
    Bernier R; Tremblay M
    J Virol; 1995 Jan; 69(1):291-300. PubMed ID: 7983721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabies serogroup viruses in neuroblastoma cells: propagation, "autointerference," and apparently random back-mutation of attenuated viruses to the virulent state.
    Clark HF
    Infect Immun; 1980 Mar; 27(3):1012-22. PubMed ID: 7380549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of host and virus which influence defective interfering virus mediated-protection of mice against Semliki Forest virus lethal encephalitis. Brief report.
    Barrett AD; Dimmock NJ
    Arch Virol; 1984; 81(1-2):185-8. PubMed ID: 6331348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of vesicular stomatitis virus RNA and its defective-interfering particles in individual mouse brains.
    Cave DR; Hagen FS; Palma EL; Huang AS
    J Virol; 1984 Apr; 50(1):86-91. PubMed ID: 6321804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papovaviral persistent infections.
    Norkin LC
    Microbiol Rev; 1982 Dec; 46(4):384-425. PubMed ID: 6298589
    [No Abstract]   [Full Text] [Related]  

  • 20. Is progressive multifocal leukoencephalopathy a chronic disease because of defective interfering particles or temperature-sensitive mutants of JC virus?
    Grinnell BW; Martin JD; Padgett BL; Walker DL
    J Virol; 1982 Sep; 43(3):1143-50. PubMed ID: 6292458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.